Treatment Response of High-dose and Standard-dose Rabeprazole for Extra-esophageal Reflux.
Status:
Completed
Trial end date:
2014-05-21
Target enrollment:
Participant gender:
Summary
This is a single-center, randomized, open-label clinical study to assess the treatment
response of high-dose rabeprazole compared with standard-dose rabeprazole in patients with
extra-esophageal manifestations of gastroesophageal reflux disease.